PLA2G6 guards placental trophoblasts against ferroptotic injury

The recently identified ferroptotic cell death is characterized by excessive accumulation of hydroperoxy-arachidonoyl (C20:4)- or adrenoyl (C22:4)- phosphatidylethanolamine (Hp-PE). The selenium-dependent glutathione peroxidase 4 (GPX4) inhibits ferroptosis, converting unstable ferroptotic lipid hyd...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 117; no. 44; pp. 27319 - 27328
Main Authors Beharier, Ofer, Tyurin, Vladimir A., Goff, Julie P., Guerrero-Santoro, Jennifer, Kajiwara, Kazuhiro, Chu, Tianjiao, Tyurina, Yulia Y., St Croix, Claudette M., Wallace, Callen T., Parry, Samuel, Parks, W. Tony, Kagan, Valerian E., Sadovsky, Yoel
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 03.11.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The recently identified ferroptotic cell death is characterized by excessive accumulation of hydroperoxy-arachidonoyl (C20:4)- or adrenoyl (C22:4)- phosphatidylethanolamine (Hp-PE). The selenium-dependent glutathione peroxidase 4 (GPX4) inhibits ferroptosis, converting unstable ferroptotic lipid hydroperoxides to nontoxic lipid alcohols in a tissue-specificmanner. While placental oxidative stress and lipotoxicity are hallmarks of placental dysfunction, the possible role of ferroptosis in placental dysfunction is largely unknown. We found that spontaneous preterm birth is associated with ferroptosis and that inhibition of GPX4 causes ferroptotic injury in primary human trophoblasts and during mouse pregnancy. Importantly, we uncovered a role for the phospholipase PLA2G6 (PNPLA9, iPLA2beta), known to metabolize Hp-PE to lyso-PE and oxidized fatty acid, in mitigating ferroptosis induced by GPX4 inhibition in vitro or by hypoxia/reoxygenation injury in vivo. Together, we identified ferroptosis signaling in the human and mouse placenta, established a role for PLA2G6 in attenuating trophoblastic ferroptosis, and provided mechanistic insights into the ill-defined placental lipotoxicity that may inspire PLA2G6-targeted therapeutic strategies.
Bibliography:Edited by R. Michael Roberts, University of Missouri, Columbia, MO, and approved September 8, 2020 (received for review May 12, 2020)
Author contributions: O.B., V.E.K., and Y.S. designed research; O.B., V.A.T., J.P.G., J.G.-S., K.K., C.M.S.C., C.T.W., and S.P. performed research; O.B., V.A.T., T.C., Y.Y.T., C.M.S.C., W.T.P., V.E.K., and Y.S. analyzed data; O.B., V.E.K., and Y.S. wrote the paper; V.A.T. and Y.Y.T. performed lipidomics analysis; C.M.S.C. analyzed cell images; and W.T.P. examined placenta pathology.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.2009201117